Cumberland Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $166 | $9,131 | $13,678 | $8,292 |
Gross Profit | 129 | 7,197 | 11,437 | 7,303 |
EBITDA | -3,123 | -1,774 | 47 | -795 |
EBIT | -3,160 | -3,051 | -1,279 | -1,833 |
Net Income | -4,115 | -3,138 | -1,411 | -1,940 |
Net Change In Cash | 166 | 9,131 | 13,678 | 8,292 |
Free Cash Flow | -1,612 | 387 | -40 | 154 |
Cash | 3,862 | 11,007 | 11,444 | 15,196 |
Basic Shares | 14,981 | 14,960 | 14,956 | 14,953 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $44,521 | $37,867 | $39,552 | $42,010 |
Gross Profit | 37,854 | 31,281 | 33,485 | 32,892 |
EBITDA | 2,957 | 182 | 2,485 | 332 |
EBIT | -2,328 | -5,860 | -5,617 | -4,995 |
Net Income | -2,836 | -6,479 | -6,279 | -5,570 |
Net Change In Cash | 44,521 | 37,867 | 39,552 | 42,010 |
Free Cash Flow | 4,834 | -791 | 5,640 | 6,379 |
Cash | 11,444 | 17,964 | 18,321 | 19,757 |
Basic Shares | 14,956 | 14,060 | 14,298 | 14,563 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.20 |
2026-03-31 | -$0.21 |
2025-12-31 | -$0.09 |
2025-09-30 | -$0.12 |